JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5051
ProShares Ultra NASDAQ Biotechnology
BIB
$94.1M
| $115K | ﹤0.01% |
+1,991
| New | +$112K |
2022 Q4
0 quarters
|
|
5052
iRadimed
IRMD
$1.11B
| $115K | ﹤0.01% |
4,078
+157
| +4% | +$4.49K |
2016 Q3
25 quarters
|
|
|
RIDE
5053
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $115K | ﹤0.01% |
6,714
+548
| +9% | +$12.7K |
2021 Q1
7 quarters
|
|
5054
Schwab Fundamental US Large Company Index ETF
FNDX
$27.4B
| $114K | ﹤0.01% |
6,390
+3,435
| +116% | +$60.8K |
2018 Q3
17 quarters
|
|
5055
Lands' End
LE
$314M
| $114K | ﹤0.01% |
14,807
-13,022
| -47% | -$119K |
2015 Q4
28 quarters
|
|
|
IVC
5056
DELISTED
Invacare Corporation
IVC
| $114K | ﹤0.01% |
272,526
+8,327
| +3% | +$4.48K |
2016 Q1
27 quarters
|
|
5057
Aura Biosciences
AURA
$645M
| $113K | ﹤0.01% |
10,746
+733
| +7% | +$9.33K |
2021 Q4
4 quarters
|
|
5058
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$695M
| $113K | ﹤0.01% |
1,832
+1,682
| +1,121% | +$105K |
2022 Q2
2 quarters
|
|
5059
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$575M
| $113K | ﹤0.01% |
+2,008
| New | +$116K |
2022 Q4
0 quarters
|
|
5060
PepGen
PEPG
$163M
| $113K | ﹤0.01% |
8,476
+3,285
| +63% | +$42.4K |
2022 Q2
2 quarters
|
|
5061
Greene County Bancorp
GCBC
$584M
| $112K | ﹤0.01% |
3,910
+208
| +6% | +$6.93K |
2017 Q4
20 quarters
|
|
5062
PUT
FerroAtlántica
GSM
$818M
| $112K | ﹤0.01% |
29,100
| – | – |
2022 Q2
2 quarters
|
|
5063
NextNav
NN
$2.25B
| $112K | ﹤0.01% |
38,224
+1,769
| +5% | +$5.44K |
2022 Q2
2 quarters
|
|
5064
Invesco Water Resources ETF
PHO
$1.92B
| $112K | ﹤0.01% |
2,165
+598
| +38% | +$30.2K |
2017 Q4
20 quarters
|
|
|
FREE
5065
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $112K | ﹤0.01% |
27,502
+5,286
| +24% | +$19.2K |
2021 Q2
6 quarters
|
|
|
AFMD
5066
DELISTED
Affimed
AFMD
| $111K | ﹤0.01% |
9,015
+175
| +2% | +$3.07K |
2019 Q2
14 quarters
|
|
5067
Spire Global
SPIR
$426M
| $111K | ﹤0.01% |
14,482
+5,939
| +70% | +$58K |
2021 Q3
5 quarters
|
|
5068
Invesco S&P Global Water Index ETF
CGW
$1.03B
| $110K | ﹤0.01% |
+2,357
| New | +$109K |
2022 Q4
0 quarters
|
|
|
ISD
5069
PGIM High Yield Bond Fund
ISD
$383M
| $110K | ﹤0.01% |
+9,233
| New | +$111K |
2022 Q4
0 quarters
|
|
5070
Organogenesis Holdings
ORGO
$166M
| $110K | ﹤0.01% |
40,781
-24,407
| -37% | -$71.2K |
2019 Q1
15 quarters
|
|
|
PR
5071
PUT
Permian Resources
PR
$18.6B
| $110K | ﹤0.01% |
11,700
| – | – |
2021 Q1
7 quarters
|
|
5072
Century Casinos
CNTY
$29M
| $109K | ﹤0.01% |
15,516
+590
| +4% | +$4.32K |
2017 Q4
20 quarters
|
|
5073
Holley
HLLY
$278M
| $109K | ﹤0.01% |
51,508
+4,221
| +9% | +$13.3K |
2021 Q4
4 quarters
|
|
5074
iShares US Industrials ETF
IYJ
$2.02B
| $109K | ﹤0.01% |
1,126
+410
| +57% | +$38.7K |
2015 Q4
28 quarters
|
|
|
KNTE
5075
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $109K | ﹤0.01% |
17,918
-1,156
| -6% | -$9.41K |
2021 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.